HBB Full Gene Sequencing Coding and Billing Guidelines (CM00039 V3)
Skip to main content


October 19, 2015 - Revised 10.13.17

HBB Full Gene Sequencing Coding and Billing Guidelines (CM00039, V3)

Effective for dates of service on and after May 3, 2013

HBB gene testing may be performed during the diagnosis of Sickle cell disease (SCD). Since clinical symptoms and diagnosis usually occur prior to Medicare eligibility and carrier testing is not a covered benefit, the MolDX team has determined HBB full gene sequencing is a statutorily excluded test. MolDX will also deny panels of tests that include the HBB gene.

To receive a HBB gene sequencing service denial, please submit the following claim information:

  • Select the appropriate CPT code based on gene test:
    • CPT code 81401 – HBB, common variants
    • CPT code 81403 - HBB, duplication/deletion
    • CPT code 81404 – HBB, full gene sequence
  • An Advance Beneficiary Notice of Non-Coverage (ABN)External website is not required for statutorily excluded services
  • Select the appropriate diagnosis for the patient
  • Enter the appropriate DEX Z-code™Identifier adjacent to the CPT code in the comment/narrative field for the following claim field/types:
    • Part A: Line SV202-7 (electronic claim); Block 80 (paper claim)
    • Part B: Loop 2400, NTE02, or SV101-7 (electronic claim); Box 19 (paper claim)

Reference: Sec. 1862 (1)(A) Statutory Exclusion covers diagnostic testing "except for items and services that are not reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member,…"

26 Century Blvd Ste ST610, Nashville, TN 37214-3685 © CGS Administrators, LLC. All Rights Reserved